182 related articles for article (PubMed ID: 23860208)
1. Effect of amphipathic HIV fusion inhibitor peptides on POPC and POPC/cholesterol membrane properties: a molecular simulation study.
Martins do Canto AM; Carvalho AJ; Ramalho JP; Loura LM
Int J Mol Sci; 2013 Jul; 14(7):14724-43. PubMed ID: 23860208
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics simulations of T-2410 and T-2429 HIV fusion inhibitors interacting with model membranes: Insight into peptide behavior, structure and dynamics.
Mavioso ICVC; de Andrade VCR; Palace Carvalho AJ; Martins do Canto AMT
Biophys Chem; 2017 Sep; 228():69-80. PubMed ID: 28711675
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulation of HIV fusion inhibitor T-1249: insights on peptide-lipid interaction.
Martins do Canto AM; Palace Carvalho AJ; Prates Ramalho JP; Loura LM
Comput Math Methods Med; 2012; 2012():151854. PubMed ID: 22675399
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics simulations of T-20 HIV fusion inhibitor interacting with model membranes.
do Canto AM; Carvalho AJ; Ramalho JP; Loura LM
Biophys Chem; 2011 Dec; 159(2-3):275-86. PubMed ID: 21868145
[TBL] [Abstract][Full Text] [Related]
5. HIV fusion inhibitor peptide T-1249 is able to insert or adsorb to lipidic bilayers. Putative correlation with improved efficiency.
Veiga AS; Santos NC; Loura LM; Fedorov A; Castanho MA
J Am Chem Soc; 2004 Nov; 126(45):14758-63. PubMed ID: 15535700
[TBL] [Abstract][Full Text] [Related]
6. Decoding distinct membrane interactions of HIV-1 fusion inhibitors using a combined atomic force and fluorescence microscopy approach.
Franquelim HG; Gaspar D; Veiga AS; Santos NC; Castanho MA
Biochim Biophys Acta; 2013 Aug; 1828(8):1777-85. PubMed ID: 23500616
[TBL] [Abstract][Full Text] [Related]
7. The improved efficacy of Sifuvirtide compared with enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance.
Cao P; Dou G; Cheng Y; Che J
PLoS One; 2017; 12(2):e0171567. PubMed ID: 28207776
[TBL] [Abstract][Full Text] [Related]
8. Sifuvirtide screens rigid membrane surfaces. establishment of a correlation between efficacy and membrane domain selectivity among HIV fusion inhibitor peptides.
Franquelim HG; Loura LM; Santos NC; Castanho MA
J Am Chem Soc; 2008 May; 130(19):6215-23. PubMed ID: 18410103
[TBL] [Abstract][Full Text] [Related]
9. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors.
Zhu Y; Ding X; Yu D; Chong H; He Y
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619552
[TBL] [Abstract][Full Text] [Related]
10. On the microscopic and mesoscopic perturbations of lipid bilayers upon interaction with the MPER domain of the HIV glycoprotein gp41.
Oliva R; Emendato A; Vitiello G; De Santis A; Grimaldi M; D'Ursi AM; Busi E; Del Vecchio P; Petraccone L; D'Errico G
Biochim Biophys Acta; 2016 Aug; 1858(8):1904-13. PubMed ID: 27179640
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action.
Hollmann A; Matos PM; Augusto MT; Castanho MA; Santos NC
PLoS One; 2013; 8(4):e60302. PubMed ID: 23565220
[TBL] [Abstract][Full Text] [Related]
12. Putative role of membranes in the HIV fusion inhibitor enfuvirtide mode of action at the molecular level.
Veiga S; Henriques S; Santos NC; Castanho M
Biochem J; 2004 Jan; 377(Pt 1):107-10. PubMed ID: 14514352
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the water defect at the HIV-1 gp41 membrane spanning domain in bilayers with and without cholesterol using molecular simulations.
Baker MK; Gangupomu VK; Abrams CF
Biochim Biophys Acta; 2014 May; 1838(5):1396-405. PubMed ID: 24440660
[TBL] [Abstract][Full Text] [Related]
14. Fusion of raft-like lipid bilayers operated by a membranotropic domain of the HSV-type I glycoprotein gH occurs through a cholesterol-dependent mechanism.
Vitiello G; Falanga A; Petruk AA; Merlino A; Fragneto G; Paduano L; Galdiero S; D'Errico G
Soft Matter; 2015 Apr; 11(15):3003-16. PubMed ID: 25734956
[TBL] [Abstract][Full Text] [Related]
15. Nonpolar interactions between trans-membrane helical EGF peptide and phosphatidylcholines, sphingomyelins and cholesterol. Molecular dynamics simulation studies.
Róg T; Murzyn K; Karttunen M; Pasenkiewicz-Gierula M
J Pept Sci; 2008 Apr; 14(4):374-82. PubMed ID: 17985365
[TBL] [Abstract][Full Text] [Related]
16. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential.
Buzón V; Cladera J
Biochemistry; 2006 Dec; 45(51):15768-75. PubMed ID: 17176099
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.
Lu L; Tong P; Yu X; Pan C; Zou P; Chen YH; Jiang S
Biochim Biophys Acta; 2012 Dec; 1818(12):2950-7. PubMed ID: 22867851
[TBL] [Abstract][Full Text] [Related]
18. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
[TBL] [Abstract][Full Text] [Related]
19. Molecular interactions of Alzheimer amyloid-β oligomers with neutral and negatively charged lipid bilayers.
Yu X; Wang Q; Pan Q; Zhou F; Zheng J
Phys Chem Chem Phys; 2013 Jun; 15(23):8878-89. PubMed ID: 23493873
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol effects on a mixed-chain phosphatidylcholine bilayer: a molecular dynamics simulation study.
Róg T; Pasenkiewicz-Gierula M
Biochimie; 2006 May; 88(5):449-60. PubMed ID: 16356621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
